Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0297

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 80425-0297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Description (Description)

Description (Description)
FDA Label Image

Label 1 (Venlafaxine HCl Er 150mg 80425 0297 01)

Label 1 (Venlafaxine HCl Er 150mg 80425 0297 01)
This is a pack of Venlafaxine HCL ER 150mg capsules, containing 30 capsules. The source of the medication is NOC with a code of 65862-0697-05 and the item number is 80425-0197-01. The expiry date is shown as 7/31/2025 and the IR number is given as 000000137808.*
FDA Label Image

Label 2 (Venlafaxine HCl Er 150mg 80425 0297 02)

Label 2 (Venlafaxine HCl Er 150mg 80425 0297 02)
FDA Label Image

Label 3 (Venlafaxine HCl Er 150mg 80425 0297 03)

Label 3 (Venlafaxine HCl Er 150mg 80425 0297 03)
This is a medication description for Venlafaxine HCL ER 150mg Capsules. The package contains 90 capsules with Lot number XROO0KKX and a serial number of 000000137305. The National Drug Code (NDC) is 80425-0207-03, and the source is NOC: 65862-0697-05. The medication is set to expire on July 31st, 2025.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
This appears to be a chart or table showing different populations with specific health conditions or genetic variations, as well as different analytes (perhaps blood or urine samples) and their fold change relative to a reference value. The values in the chart may be difficult to interpret without further context or explanation.*
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
This document appears to be a table showing drug interactions and their effects on various analytes and PK measures, such as Cmax and AU. The drugs listed include ethanol, aprazolam, indinavir, metoprolal, risperidone, haloperidol, caffeine, tolbutamide, and lithium. The table also includes fold change and 90% CI values relative to a reference value.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.